DS-8201a
DS8201-0001-CIS-MA
Phase 2 small_molecule active
Quick answer
DS-8201a for Unresectable and/or Metastatic HER2-low or HER2 Immunohistochemistry (IHC) 0 Breast Cancer is a Phase 2 program (small_molecule) at Daiichi Sankyo Europe GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo Europe GmbH
- Indication
- Unresectable and/or Metastatic HER2-low or HER2 Immunohistochemistry (IHC) 0 Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active